Aeterna Zentaris Inc AEZS-CA:Toronto Stock Exchange

*Data is delayed | Exchange | CAD
Last | 03/28/24 EDT
2.91quote price arrow up+0.08 (+2.83%)
Volume
2,920
52 week range
1.91 - 4.48
Loading...
  • Open3.01
  • Day High3.01
  • Day Low2.80
  • Prev Close2.83
  • 52 Week High4.48
  • 52 Week High Date04/25/23
  • 52 Week Low1.91
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap10.13M
  • Shares Out4.86M
  • 10 Day Average Volume2,873.4
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change13.23

KEY STATS

  • Open3.01
  • Day High3.01
  • Day Low2.80
  • Prev Close2.83
  • 52 Week High4.48
  • 52 Week High Date04/25/23
  • 52 Week Low1.91
  • 52 Week Low Date11/01/23
  • Market Cap10.13M
  • Shares Out4.86M
  • 10 Day Average Volume2,873.4
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change13.23

RATIOS/PROFITABILITY

  • EPS (TTM)-4.52
  • P/E (TTM)-0.64
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aeterna Zentaris Inc

 

Profile

MORE
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin...
Carolyn Egbert J.D., Ph.D.
Non-Executive Independent Chairman of the Board
Klaus Paulini Ph.D.
President, Chief Executive Officer, Director and Managing Director - AEZS Germany
Giuliano La Fratta
Chief Financial Officer, Senior Vice President
Address
315 Sigma Drive
Summerville, NB
29486
Canada

Top Peers

SYMBOLLASTCHG%CHG
PRTG
Portage Biotech Inc
0.5633UNCHUNCH
EDSA
Edesa Biotech Inc
4.15UNCHUNCH
ATE
KTRA
Kintara Therapeutics Inc
0.104UNCHUNCH
APLI